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Abstract
Recent research established a link between the development of autism
spectrum disorder (ASD) and increased levels of extra-axial cerebrospinal
fluid (EA-CSF) [30]. Along with morphometric measures, local measures
such as EA-CSF enlargement have also been shown to be relevant in a
classification model of ASD from brain magnetic resonance imaging (MRI)
images of infants aged 6 months [22]. To analyze the predictive usefulness
of the 12-month MRI data as compared to the 6-month data, I extracted
local EA-CSF measures from 12-month MRIs in Infant Brain Imaging
Study (IBIS) subjects. I then adapted the 6-month model for use with
the 12-month measurements. While I hypothesized that the 12-month
features would prove more predictive than the 6-month features, my cur-
rent findings are that for almost all brain morphometric measurements,
the adapted classifiers performed more weakly on the 12-month data set
than on the 6 month data. I explore some possible underlying reasons
in this study. Further research is needed, however, to determine whether
a combination of brain morphometric measurements or additional classi-
fier optimization may lead to a sufficiently accurate prediction for clinical
predictive use.
Approved by:
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According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV-TR) published by the American Psychiatric Association (APA), autism spec-
trum disorder (ASD) is primarily characterized by the following traits [1]:
• difficulties in social situations; and
• repetitive behavioral patterns.
The Centers for Disease Control (CDC) reports prevalence levels of approx-
imately 1 in 69 (≈ 1.45%) among children aged 8 years among Autism and
Developmental Disabilities Monitoring (ADDM) Network sites in 2012 [3]. The
CDC qualifies this figure by clarifying that these levels do not generalize to
the United States population because the ADDM sites are not representative
samples; globally the figure is closer to 62 in 10,000 (= 0.62%) [7].
Currently ASD requires diagnostic tests administered by clinicians. While
considered reliable as early as 2 years of age, ASD does not have a stable di-
agnosis as children can “age in” or “age out” of the disorder depending on the
severity of the symptoms [19]. The medical community generally recognizes
that interventions are more effective earlier than later; it is known that ear-
lier interventions have the greatest impact on the lives of those diagnosed with
ASD [32]. Unfortunately, because diagnosing ASD so early is not yet possi-
ble, no such early interventions have yet been developed, though progress is
underway based on current results. There is thus strong interest in developing
early-warning or early-diagnostic systems. Care must be taken so that these
systems do not cause harm by falsely predicting ASD. At this time there are
no known and accepted biological markers for ASD that can aid clinicians in
diagnosis or staging.
1.2 Problem
For subjects at high familial risk (HR) for ASD, previous research has
• established a correlation between ASD and increased extra-axial cere-
brospinal fluid (EA-CSF) [30, 29];
• established the predictive accuracy of surface-area based diagnoses [13];
and
• developed ASD classifiers with the application of increasingly-popular
deep-learning methods [22].
This has set the stage for local EA-CSF and other morphometric features—
such as surface area (SA), cortical thickness (CT), and surface complexity index
(SCI) [17]—of the brain to be early biological markers of ASD. While it is too
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early for these markers to be employed for clinical diagnoses, it is now considered
feasible to develop early-warning systems in the high-risk population for ASD
based on these markers. Current results have not been extended to the general
population, but ongoing efforts at University of North Carolina (UNC) and the
University of Minnesota are working on early identification of a behaviorally-
defined ASD risk population as early as 12 months of age [27].
In this work I set out to explore the predictive power of the above mentioned
morphometric features within the HR population at 12 months as compared to
existing results in their 6-month counterparts. This is an important intermediate
step to investigate whether morphometric features could be employed as early
biomarkers in a generally-defined HR population.
2 Methods
2.1 Data
My primary dataset comes from Infant Brain Imaging Study (IBIS) [24], which
is also the basis for a number of other related works, including [22, 30, 17].
Participants in the IBIS study are infants at HR and low familial risk (LR)1
and were enrolled at four clinical sites in the United States: UNC, University
of Washington, Washington University in St. Louis, and Children’s Hospital of
Philadelphia [33]. Hazlett et al. report recruitment and exclusionary criteria for
this sample [12].
Data from IBIS takes the form of cases; each documents a unique person
and records demographic information, a series of magnetic resonance imaging
(MRI) images (raw T1w and T2w) from 6 to 24 months, and a professional ASD
diagnosis at around 24 months of age. In this work, I focus on the 12-month
MRI images, of which there are about 900. Hazlett et al. describe the MRI
acquisition process in detail in [12], and Hazlett et al. describe the processing
steps to extract tissue segmentations, cortical surface reconstructions, CT, SA,
and SCI in [13].
In order to apply a classifier which uses local EA-CSF measures I first pro-
cessed these MRI images to establish estimates of local EA-CSF volumes at the
cortical surface. The data-processing pipeline is summarized in Figure 1 and
explained in detail in Section 2.1.1. The amount of usable cases per stage is









Figure 1: Stages of data processing pipeline




Attempted EA-CSF computation 757
EA-CSF computation 410
EA-CSF quality control (Loose) 343
EA-CSF quality control (Strict) 291
Merge EA-CSF with case information (Loose) 255
Merge EA-CSF with case information (Strict) 220
Merge SA, CT, SCI with case information 312
Table 1: Subject counts by stage of processing. See Section 2.1.1 for details
about the inclusion criteria (designated Loose and Strict).
The final tallies for local EA-CSF merged with case information include
filtering done to remove cases where certain input data was unavailable (see
Section 2.2.3).
The last item in Table 1, merging case information with SA, CT, SCI data,
is unrelated to local EA-CSF processing but shows an important reduction in
the amount of usable data. During that stage I only merged the available
morphometric data with the case information for the 410 cases for which I had
processed local EA-CSF.
2.1.1 Data processing
As shown in Figure 1, I undertook 3 main steps to process the 12-month MRI
images:
1. Extract local EA-CSF
2. Quality-control check the processed EA-CSF
3. Merge with case information
First, I made use primarily of work in [28] to extract the local EA-CSF,
which is also explored in [22]. With the resources of University of North Car-
olina’s SLURM [34] cluster, I used a brain mask, reconstructed white-matter
and grey-matter surfaces, and a CSF probability map to compute the local EA-
CSF volume at 163,848 points in the brain. Then I computed regional sums
for different parcellations2; in this study I used the AAL, Destrieux, and Gor-
don parcellations. Next I performed a quality-control check on the processed
cases (summarized below). Finally, I merged the computed measures with de-
mographic and diagnosis data. The most common reason for exclusion during
or before EA-CSF-computation was missing input data.
2this assists with dimensionality reduction; see Section 2.2.2
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Figure 2: EA-CSF extraction pipeline (adapted from [28] and [22])
As shown in Figure 2, first a probabilistic tissue segmentation of white mat-
ter (WM), gray matter (GM), and EA-CSF was performed, followed by a re-
construction of the outer WM, GM, and EA-CSF surfaces. Then, I solved a
Laplacian partial differential equation between the inner surfaces and the EA-
CSF outer surface to generate a vector field connecting the surfaces. I sampled
the field along these connections in order to integrate EA-CSF probability values
and to quantify local EA-CSF measures at each point in the cortical surface, of
which there are 163,848. I used tools such as [16, 15, 14], as well as code custom-
made by Mostapha [22]. Shen et al. and Mostapha discuss this extraction in
more detail [28, 22].
For the quality-control check, I labelled each sample as either good (0),
borderline (1), or bad (2). A “good” label indicates that the sample shows
only minor errors either on the edges or in regions of the brain not of interest
to my study. A “borderline” label indicates larger but sporadic errors. A
“bad” label indicates the largest of errors, that the sample is useless as input
to my models; often entire regions or hemispheres are missing. The quality-
control check performed was subjective and conducted by a non-expert, but
was subject to guidance and input from experts. See Figure 3 for examples
of the quality-control labels. These quality-control labels form the basis of my
inclusion criteria:
Strict Only cases which were classified good (0)
Loose Only cases which were classified good (0) or borderline (1)
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(a) Good (0)
(b) Borderline (1): Notes indicate missing
regions on the left hemisphere
(c) Bad (2): Notes indicate missing entire
right hemisphere
Figure 3: Quality-control examples
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2.1.2 Data classification
The final available data (the last three items of Table 1: each of my 4 morpho-
metric feature sets merged with case information) breaks down as follows. Cases
are classified along two axes: risk and ASD diagnosis. A case may be either HR
or LR; in addition, a case is either diagnosed with ASD (+) or without (−).
These axes are summarized in Table 2, which is additionally broken down via
the Strict and Loose quality-control inclusion criteria.
The HR designation is given when an older sibling has an ASD diagnosis.
Research has shown that the recurrence risk for ASD is between 15 and 20
percent [25], meaning that, among HR-designated cases, the risk of developing
ASD is statistically more likely when compared with the general population. To
summarize:
HR High familial risk. Participant has at least one older sibling with diagnosed
ASD [8].
LR Low familial risk. Participant has a typically-developing older sibling and
no first-degree relatives with ASD or intellectual disabilities [8].
LR HR
Strict Loose Strict Loose
ASD+ 2 2 32 37
ASD− 56 69 130 147
Table 2: Axes along which a case is classified
In addition, cases were classified along the ADOS [20] and Mullen [23] axes,
which measure atypicality via administered tests. I excluded from the final data
any cases considered atypical on the ADOS or Mullen scales.
2.2 Models
I considered 3 sets of machine-learning models in studying the early prediction
of ASD. Each set consists of a pair of models, wherein I shrank the available
data to fit the size of either the Strict or Loose inclusion criteria to form my
input (see Section 2.1.2). I summarize the input data features in Section 2.2.3.
First, I considered each feature individually based on hyper-parameters from
the 6-month model—this yielded 12 different models, one per feature per par-
cellation (see Section 2.2.4). Then, I considered the 6-month model applied
to the 12 month features, again based on hyper-parameters from the 6-month
model (see Section 2.2.5). Finally, I considered the 6-month model adapted
based on the best-performing individual models at 12-months, again based on
hyper-parameters from the 6-month models (see Section 2.2.6).
Each model was built as a Python3 program using the scikit-learn [26]
and tensorflow [21] packages. All model diagrams were made courtesy of
LeNail’s tool, NN-SVG [18]. I present the results in Section 3.
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It is known that non-linear differences exist in male and brain development.
Further, it is also known that ASD presents a broad, heterogeneous spectrum of
phenotypes and symptoms. Neural networks and deep-learning in particular are
capable of and well-suited to learning multiple disjoint, non-linear associations.
This makes them well-suited to studying problems of brain development and
ASD, since those problems exhibit characteristics compatible with the capabil-
ities of neural networks. Next, I will give a very brief introduction to neural
networks and deep-learning.
2.2.1 Brief overview of neural networks and deep-learning
Neural networks are fundamentally composed of layers of linear and non-linear
functions. For example, the classic multi-layer perceptron (MLP) [11], the origin
of binary classification via neural networks, can be viewed as a logistic regres-
sor where the input is transformed using a learned non-linear transformation.
One layer—a hidden-layer—is sufficient to make an MLP a universal approx-
imator [4]. Deep-learning, then, stacks many such layers, for which there are
substantial benefits [9]. Deep neural networks are capable of learning non-linear
associations and even multiple, disjoint associations.
Figure 4: Example MLP network (1 hidden layer)
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Figure 5: Example deep-learning neural network with several hidden layers
2.2.2 Handling high-dimensional data
Perhaps the most difficult problems facing machine-learning models are (a) over-
fitting (i.e., not generalizing well); and (b) a dearth of data. A lack of data often
makes overfitting more likely, especially when the data is high-dimensional, as
in the case of 163,848 input features from a brain. Common techniques to
combat small amounts of high-dimensional data include supervised and unsu-
pervised dimensionality reduction, which essentially reduce the feature space
and therefore the number of model parameters. Unsupervised methods risk
losing important information, making the results inadequate for classification,
while supervised methods risk biasing the models, making the resulting models
harder to generalize.
One alternative is to pursue domain-specific knowledge in dimensionality
reduction. To do this, I employed the same method as the original 6-month
classification: regional summaries [22].
The adult brain can be divided into different regions; such a division is called
a parcellation and comes equipped with an atlas that designates which brain
vertices belong to which regions. These divisions can be performed based on
the anatomy of the brain, as in the Lobar, Desikan-Killiany [5], AAL [31], and
Destrieux [6] parcellations, or based on functional labelling, as in the Gordon
parcellation [10]. The number of regions per parcellation is summarized in
Table 3.
For the 12-month data I only had readily available the AAL, Destrieux, and
Gordon parcellations, whereas the 6-month data had access to all 5 parcellations.
Adult brain parcellations were applied to infant brains in both works.
I used these parcellations to reduce the dimensionality of input data for
the machine-learning models. I summed the EA-CSF measures at the 163,848
vertices, bucketed by region, to produce the parcellated inputs.
2.2.3 Input data
I used only the HR subjects as model inputs.
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Table 3: Number of regions per parcellation
Figure 6: AAL and Gordon (Functional) parcellations, used for domain-specific
dimensionality reduction via regional summary
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For my 4 morphometric features (EA-CSF, SA, CT, and SCI), I had 3 avail-
able parcellations: the AAL, the Destrieux, and the Gordon. The morphometric
features are summarized in Figure 7.
EACSF Local extra-axial cerebrospinal fluid (total volume per region) [28]
SA Surface area
CT Cortical thickness
SCI Surface complexity index [17]
Figure 7: Regional input data
I also had demographic information available for each case. I used only
intra-cranial cavity volume (ICV), sex, and MRI age, which is summarized in
Figure 8.
ICV Intra-cranial cavity volume
Sex Male/Female, mapped to a 0/1 index
MRI Age Age (in fractions of years) at scan
Figure 8: Subject input data
All of the numerical features were rescaled using Z-score normalization, giv-
ing the input features 0 mean and unit variance. I did this using scikit-learn’s
StandardScaler preprocessing class [26].
The combination of regional input data and subject input data per case
formed the input to my models. Each model specifies which parcellation was
used for regional input data, and it also used all of the subject input data.
2.2.4 Individual models
Before considering any of my features in combination, it was important to evalu-
ate the predictive power of isolated features. After all, previous research showed
promise using only SA-based predictions [13]. In addition, I wanted to be able
to compare my results to the individual models from the 6-month study.
I thus built twelve neural networks, one per morphometric feature per avail-
able parcellation. Each included the subject data as defined in Figure 8, and
a single item from the regional input data as defined in Figure 7. Thus the 12
models can be summarized as in Table 4.
Each network had two hidden layers and an output layer. The output layer
consisted of a single neuron with a sigmoid activation function, which produces
a single number in the interval [0, 1]. This output was thresholded to produce a
13

















Table 4: Summary of individual model regional inputs
single classification. Given a threshold t and output p, I can make the following
determination: {
p > t Predict ASD+
p ≤ t Predict ASD−
This structure is summarized in Figure 9.
I had a set of prior thresholds determined experimentally by Mostapha for
the 6-month ensemble model (one per training fold in his experiments); I used
the median threshold of these thresholds (over all folds) as t for each model in
order to maintain similarities between this study and the 6-month study [22].
The hidden layers used l2 regularization and batch normalization to constrain
the network, following the suit of the 6-month models.
To deal with the class imbalance demonstrated in Table 2, I employed
SMOTE, which created synthetic samples from the minority class (HR, ASD+)
to balance the number of samples in the majority class (HR, ASD−) [2]. I used
these samples only to train the network, not to evaluate it.
I compiled the models using stochastic gradient descent with Nesterov’s Ac-
celerated Gradient optimization. I used a weighted binary cross-entropy loss-
function to measure the difference between network predictions and actual ASD
diagnoses.
Thanks to code from Mostapha, I duplicated the full network architecture
for each of the models (e.g., hidden-layer size, dropout rate, learning rate, l2
regularization weight, batch size, epochs) from the corresponding input feature
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Figure 9: A sample binary classifier architecture. Final decision made via
thresholding the output p > t
in the 6-month model. These hyper-parameters were set using a grid-search [22]
in the 6-month model. For example, each of the surface area (SA) models used
the same hyper-parameters—those from the SA portion of the 6-month ensemble
model. I made no further attempts to optimize the network architecture, despite
the possibility of improved performance.
2.2.5 Adapted 6-month ensemble model
Having examined the individual morphometric features, Mostapha looked at
combining features to increase the overall predictive power [22]. Mostapha de-
veloped an ensemble model whose structure is shown in Figure 10. I followed
suit and replicated the ensemble model for the 12-month data.
An ensemble model generally refers to a collaborative model consisting of
n models and a decision-making strategy to combine their results into a single
decision output [35]. The ensemble model developed for the 6-month features
used a soft voting strategy that weighted each component model’s outputs and
summed them to form the final prediction [22]. For this strategy, one starts
with n component predictions p1, . . . , pn. One then chooses (by some process;






A threshold is then chosen to make the final binary classification as before:
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{
p > t Predict ASD+
p ≤ t Predict ASD−
(a) p1 (b) p2
(c) p3 (d) p4
Figure 10: Example ensemble model with n = 4. Final prediction made via
weighted vote p =
∑
i wipi > t.
The 6-month ensemble model employs this structure with n = 4, one model
per morphometric feature. Each uses the “optimal” parcellation as determined
experimentally by Mostapha [22]. These features are
1. surface area (SA) (Lobar);
2. surface complexity index (SCI) (Destrieux);
3. extra-axial cerebrospinal fluid (EA-CSF) (Gordon); and
4. cortical thickness (CT) (AAL)
In the 6-month ensemble model, t and w1, . . . , w4 were chosen experimentally
via grid-search [22].
To construct a comparable 12-month model, I kept the same structure from
Figure 10 but gave as input the 12-month features. Pre-processing and hyper-
parameters are the same as described in Section 2.2.4; that is, I used exactly the
same structure between the 6-month ensemble model and the adapted version for
12-month features, with one significant difference. I did not have access at time
of writing to the Lobar parcellation, so I substituted in the AAL parcellation
instead. I chose AAL as a reasonable substitute because it was the lowest-
dimensional parcellation available (the Lobar parcellation has only 8 regions);
best would have been to recover the Lobar parcellation.
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I also chose t to be the median of the experimentally-determined 6-month
thresholds, as in the individual models. Given one set of weights w1, . . . , w4 per
fold, I again employed the median of each weight across the folds as a reasonable
substitute for the actual weights. The experimentally determined weights are
again too specific to the folds used in training 6-month ensemble model.
As before, I made no further attempts to optimize the network architecture,
despite the possibility of improved performance.
2.2.6 Adapted 12-month ensemble model
I recognized that the adapted 6-month model assumed that the most predic-
tive morphometric feature/parcellation combinations at 6 months of age would
continue to be the most predictive input for 12 months. To investigate the
possibility that changes in anatomical features during development changed the
relative predictive power of input features, I built a second ensemble model
whose inputs were the most predictive when evaluating individual predictive
power at 12 months. The “most predictive” models were chosen by consider-
ing elevated positive predictive value and maintained or increased additional
attributes.
For the Strict inclusion criteria, I chose the following parcellations:
1. surface area (SA) (Gordon);
2. surface complexity index (SCI) (AAL);
3. extra-axial cerebrospinal fluid (EA-CSF) (Destrieux); and
4. cortical thickness (CT) (AAL or Gordon)
For the Loose inclusion criteria, I chose the following parcellations:
1. surface area (SA) (Gordon);
2. surface complexity index (SCI) (AAL);
3. extra-axial cerebrospinal fluid (EA-CSF) (AAL); and
4. cortical thickness (CT) (Destrieux)
I kept the architecture between the two ensemble models exactly the same,
including the weights and threshold used, the size of hidden layers, etc.
3 Results
See Section 2.2 for a detailed presentation of the evaluated models.
I evaluated each model via a stratified 10-fold cross-validation scheme, made
possible by scikit-learn’s StratifiedKFold class [26], following the scheme of
the 6-month model evaluation. For each of the 10 folds, each case was assigned to
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either the training set (approximately 90%) or the validation set (approximately
10%). Each case was in the validation set exactly once. The stratification
attempts to maintain the input data distribution across each fold so that they
are representative of the entire dataset.
For each fold and for each component model, I trained multiple models
(n = 99) to get results robust to random weight initialization and random
dropout selection. Given these n probabilities p1i , . . . , p
n
i for model i, I computed






i , the average across all
n. This is ultimately the probability pi used for combination in the ensemble
model. I chose n = 99 so that (a) I avoided an even number of votes and thus
avoided ties; and (b) I had enough models to meaningfully average and across
differences in the stochastic process.
I present the results using the standard binary classification measures3: ac-
curacy (ACC), sensitivity (SEN), specificity (SPC), positive predictive value
(PPV), and negative predictive value (NPV). Each is defined in terms of true
positives (TP), true negatives (TN), false positives (FP), and false negatives
(FN). Here, TP indicates that the model correctly predicts an ASD+ diagnosis,
while FN indicates that the model incorrectly predicts an ASD− diagnosis. The
5 measures are defined below:
ACC Accuracy = TP+TNTP+TN+FP+FN
SEN Sensitivity = TPTP+FN
SPC Specificity = TNTN+FP
PPV Positive predictive value4 = TPTP+FP
NPV Negative predictive value = TNTN+FN
I report the results as the average across each of the 10 folds. Each is given
as a percentage.
3.1 Results for individual models
I first present the original results from the 6-month individual models [22] in
Table 5. These models had access to additional parcellations; namely, the Lobar
and Desikan-Killiany.
Finally, I present the results from the models described in Section 2.2.4. I
present the data first by Strict inclusion (Table 6) and then by Loose inclusion
(Table 7) as defined in Section 2.1.2.
In each table, I bolded the best performing parcellation by model, which
I evaluated by considering both higher relative PPV and similar or increased
other attributes, as in the 6-month study [22]. I favor elevated PPV because
3For a more in-depth discussion, the Wikipedia article https://en.wikipedia.org/wiki/
Evaluation_of_binary_classifiers provides a good starting point
4Considered the most important measure of diagnostic capability
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Model Parcellation ACC SEN SPC PPV NPV
SA
Lobar 75.3 62.5 78.5 44.3 89.6
Desikan-Killiany 71.6 27.5 83.2 32.3 81.9
AAL 73.8 37.5 83.3 46.1 84.5
Destrieux 76.4 35.5 87.2 38.3 84.3
Gordon 75.9 35.5 87.3 42.2 83.7
SCI
Lobar 72.1 60.8 75.2 38.4 88.5
Desikan-Killiany 79.1 51.7 85.9 52.4 83.0
AAL 77.1 43.3 85.3 49.5 86.2
Destrieux 81.4 50.8 89.3 55.1 87.9
Gordon 79.7 32.5 90.7 48.3 84.5
EA-CSF
Lobar 72.7 60.0 75.8 39.3 88.6
Desikan-Killiany 74.8 43.33 83.2 52.58 85.2
AAL 76.9 42.5 85.8 48.3 85.6
Destrieux 73.8 43.33 81.8 47.0 84.7
Gordon 77.5 38.3 87.9 53.4 84.8
CT
Lobar 75.4 31.7 86.6 33.8 83.5
Desikan-Killiany 75.9 37.5 85.9 39.0 84.4
AAL 76.5 66.7 86.6 50.0 84.5
Destrieux 75.3 32.5 86.5 34.8 83.4
Gordon 77.5 34.2 88.5 47.8 84.0
Table 5: Results of original 6-month individual models [22]. Bolding present in
original.
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it “reflects the potential clinical relevance” for such predictive tasks [22]. The
bolding in Table 5 is present in the original, and indicates Mostapha’s choice of
models [22].
Model Parcellation ACC SEN SPC PPV NPV
SA
AAL 64.3 59.2 65.4 32.0 86.6
Destrieux 64.9 55.0 66.9 27.8 87.2
Gordon 74.1 65.0 76.2 41.5 90.4
SCI
AAL 63.6 47.5 67.7 26.9 84.7
Destrieux 55.7 43.3 58.5 19.4 81.2
Gordon 44.5 65.0 39.2 21.7 80.5
EA-CSF
AAL 65.9 30.8 74.6 21.5 81.4
Destrieux 66.5 30.8 75.4 28.5 81.5
Gordon 65.4 22.5 76.2 24.2 80.0
CT
AAL 70.9 40.0 78.5 31.7 84.5
Destrieux 66.7 33.3 74.6 22.8 82.5
Gordon 70.9 36.7 79.2 34.3 83.7
Table 6: Results of individual (Strict) models
As shown in Table 6, the SA models at 12-months exhibit higher SEN (AAL:
59.2%; Destrieux: 55.0%; Gordon 65.0%) than all of the 6-month SA models
except for the Lobar parcellation (62.5%), which is exceeded only by the Gordon
parcellation at 12-months. The Gordon parcellation for SA at 12-months also
has comparable ACC (74.1%) and NPV (90.4%) to the best SA model at 6
months (ACC: 75.3%; NPV: 89.6%). I bolded two CT parcellations because they
present similar results across the 5 reported statistics. For the CT parcellations,
the AAL and Gordon parcellations had higher results in all 5 statistics than the
Destrieux parcellation. Further, the Gordon parcellation is better than the AAL
in every statistic except SEN (AAL: 40.0%; Gordon 36.7%).
When comparing Table 6 with Table 5, the best ACC in each feature is
somewhat lower in the 12-month models (74.1%, 63.6%, 66.5%, 70.9%) than in
the 6-month models (75.3%, 76.5%, 81.4%, 77.5%). More importantly, the best
12-month PPV is the SA (Gordon: 41.5%), which is still lower than all of the
best 6-month models’ PPV. This is likely attributable to (a) a lack of network
optimization in the 12-month models and (b) SA hyper-parameters optimized
for the Lobar parcellation. The most consistently comparable statistic between
the two is NPV. Its elevation likely indicates that a model still prefers the
majority class ASD−, since elevated NPV indicates strong performance on the
negative class.
In the case of Table 7, the “best” (when considering elevated PPV and
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Model Parcellation ACC SEN SPC PPV NPV
SA
AAL 60.3 54.2 62.1 29.4 84.8
Destrieux 60.2 52.5 62.8 29.0 84.1
Gordon 66.8 57.5 69.5 33.1 86.8
SCI
AAL 63.1 40.8 68.6 24.9 82.1
Destrieux 60.8 37.5 66.5 23.5 80.9
Gordon 49.4 70.8 44.2 23.8 86.3
EA-CSF
AAL 65.2 37.5 72.0 22.4 82.4
Destrieux 57.0 19.2 66.5 12.4 76.2
Gordon 59.4 15.0 70.3 12.0 76.3
CT
AAL 65.4 40.8 71.5 28.2 82.6
Destrieux 68.1 40.8 74.9 29.3 83.1
Gordon 65.9 38.3 72.9 28.1 82.2
Table 7: Results of individual (Loose) models
sustained or elevated other measures) is fortunately empirically evident. The
exception here is SEN for SCI in the chosen AAL (40.8%) versus in the Gordon
(70.3%). Given that SEN is the ratio of TP to TP +FN , there are two possible
explanations for the elevated SEN:
1. The amount of TPs is higher than in other models, indicating the model
more often correctly predicts ASD+; or
2. The amount of FN is lower than in other models, indicating the model
less frequently mis-predicted ASD−, the majority class
Given the low PPV, which also depends on TPs, I suspect the latter.
When comparing Table 7 with Table 5, the overall results are still lower,
especially in terms of ACC. Both SA (Gordon: 57.5%) and SCI (AAL: 40.8%;
Gordon: 70.8%) demonstrate elevated SEN levels for some parcellations when
compared with the original 6-month individual models (SA: best 62.5%, average
39.5%; SCI: best 66.7%, average 40.5%).
Perhaps most interestingly, PPV appears best in the Strict inclusion criteria
between the 12-month models. However, between the Strict and Loose inclusion
criteria, the best parcellation for a given feature was consistent between SA and
SCI, but not between EA-CSF and CT.
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3.2 Results for adapted 6-month ensemble model
I first present the original results from the 6-month ensemble model [22] in
Table 8.
Model Parcellation ACC SEN SPC PPV NPV
SA Lobar 75.3 62.5 78.5 44.3 89.6
SCI Destrieux 81.4 50.8 89.3 55.1 87.9
EA-CSF Gordon 77.5 38.3 87.9 53.4 84.8
CT AAL 76.5 66.7 86.6 50.0 84.5
Final 89.7 78.3 92.5 80.2 95.2
Table 8: Results of original 6-month ensemble model
Finally, I present the results from the models described in Section 2.2.5. I
present the data first by Strict inclusion (Table 9) and then by Loose inclusion
(Table 10) as defined in Section 2.1.1.
Model Parcellation ACC SEN SPC PPV NPV
SA AAL 62.9 58.3 63.8 30.6 86.3
SCI Destrieux 59.2 45.0 62.3 25.4 82.2
EA-CSF Gordon 64.9 24.2 74.6 19.6 79.8
CT AAL 66.0 43.3 71.5 28.3 83.8
Final 71.0 40.0 78.5 33.0 84.3
Table 9: Results of adapted 6-month ensemble model on 12-month data (Strict)
As shown in Table 9, the adapted ensemble model under the Strict inclusion
criteria (71.0% ACC; 40.0% SEN; 78.5% SPC; 33.0% PPV; 84.3% NPV) demon-
strates improvements to the individual model across all statistics except SEN
(40.0% compared to 58.3% in SA, 45.0% in SCI, and 43.3% in CT). Additionally,
the NPV saw a slight drop between SA (86.3%) and the final result (84.3%).
The drop in SEN is notable compared to the low SEN in EA-CSF (24.2%), which
may not be made up for by the other component models. Given the already
lower scores of the individual models, I expected the ensemble model to perform
better than the individual models but not better than the 6-month measures,
which these results confirm. All measures of the final model had lower scores
than their 6-month counterparts. In particular, I did not observe the dramatic
improvement to PPV in the 6-month ensemble model (25–35 percentage points)
in the adapted model (which shows a gain of only 3–13 percentage points).
As shown in Table 10, the adapted ensemble model under the Loose inclu-
sion criteria (70.9% ACC; 38.3% SEN; 79.2% SPC; 32.7% PPV; 84.4% NPV) is
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Model Parcellation ACC SEN SPC PPV NPV
SA AAL 66.7 60.0 68.5 32.1 87.5
SCI Destrieux 55.4 40.8 59.2 25.3 81.5
EA-CSF Gordon 62.5 20.0 73.1 11.7 78.9
CT AAL 70.4 53.3 74.6 38.2 86.7
Final 70.9 38.3 79.2 32.7 84.4
Table 10: Results of adapted 6-month ensemble model on 12-month data (Loose)
comparable to the adapted ensemble model under the Strict inclusion criteria
(71.0% ACC; 40.0% SEN; 78.5% SPC; 33.0% PPV; 84.3% NPV). One notable
difference is the increased power of the component models for SA (66.7% ACC;
32.1% PPV) and CT (70.4% ACC; 38.2% PPV) using the Loose inclusion cri-
teria when compared to the Strict inclusion criteria. This suggests that more
data can improve predictive power, even when the data is noisier. Alternatively,
it demonstrates that the most powerful predictive features at 6 months (SCI,
EA-CSF) may be less predictive at 12 months, as other measures such as SA
and CT stabilize. However, using the Loose inclusion criteria does not provide
enough of an improvement to change the final results by a large enough factor
to be comparable to the original 6-month ensemble model.
3.3 Results for adapted 12-month ensemble model
I present the results from the models described in Section 2.2.6. I present the
data first by Strict inclusion (Table 11 and Table 12) and then by Loose inclusion
(Table 13) as defined in Section 2.1.1.
Model Parcellation ACC SEN SPC PPV NPV
SA Gordon 72.2 65.0 73.8 42.3 90.2
SCI AAL 63.1 31.7 70.8 24.8 80.5
EA-CSF Destrieux 66.0 30.8 74.6 22.3 81.6
CT AAL 68.0 40.8 74.6 30.7 83.3
Final 74.1 46.7 80.8 47.4 86.1
Table 11: Results of adapted 12-month ensemble model (Strict, CT AAL)
Comparing the adapted 12-month ensemble models under the Strict inclusion
criteria in Table 11 (ACC: 74.1; SEN: 46.7; SPC: 80.8; PPV: 47.4; NPV: 86.1)
and Table 12 (ACC: 75.4; SEN: 48.3; SPC: 82.3; PPV: 34.2; NPV: 87.0) with the
adapted 6-month ensemble model under the Strict inclusion in Table 9 (ACC:
71.0; SEN: 40.0; SPC: 78.5; PPV: 33.0; NPV: 84.3), a marked improvement
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Model Parcellation ACC SEN SPC PPV NPV
SA Gordon 71.1 65.8 72.3 35.5 90.6
SCI AAL 63.6 39.2 69.2 22.1 82.3
EA-CSF Destrieux 68.0 33.3 76.9 19.4 82.9
CT Gordon 64.2 36.7 70.8 23.9 82.0
Final 75.4 48.3 82.3 34.2 87.0
Table 12: Results of adapted 12-month ensemble model (Strict, CT Gordon)
is present across the final models. It is still, however, lower than the 6-month
ensemble model results in Table 8 (ACC: 89.7; SEN: 78.3; SPC: 92.5; PPV: 80.2;
NPV: 95.2) [22]. The adapted 12-month model using the Gordon parcellation for
CT performed worse with respect to PPV (34.2%) than the adapted 12-month
using the AAL parcellation (47.4%).
Model Parcellation ACC SEN SPC PPV NPV
SA Gordon 66.8 53.3 70.2 32.0 85.8
SCI AAL 66.9 48.3 72.1 29.4 84.4
EA-CSF AAL 67.4 38.3 74.9 29.3 83.1
CT Destrieux 65.8 26.7 75.6 19.4 80.6
Final 74.0 46.7 81.0 41.4 86.0
Table 13: Results of adapted 12-month ensemble model (Loose)
Similarly, the adapted 12-month ensemble model under the Loose inclusion
criteria in Table 13 (ACC: 74.0; SEN: 46.7; SPC: 81.0; PPV: 41.4; NPV: 86.0)
presents an improvement to the corresponding adapted 6-month ensemble model
in Table 10 (ACC: 70.9; SEN: 38.3; SPC: 79.2; PPV: 32.7; NPV: 84.4), but is
worse than its Strict counterparts and than the 6-month ensemble model.
4 Discussion
I evaluated both individual models (Section 2.2.4) and ensemble models (Sec-
tion 2.2.5 and Section 2.2.6) to determine the ability of morphometric features
derived from MRI images taken at 12 months of age to correctly classify ASD.
My initial results showed that both types of models at 12 months performed
more weakly than those at 6 months in most cases, but they evidence a possible
signal, leaving room for further improvement. My study was limited by avail-
able data, suggesting further avenues of exploration. Importantly, my results
reinforce the conclusions of Mostapha and Hazlett et al. that such morphometric
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features are capable of correctly predicting ASD as early as 6–12 months in HR
populations, more than a full year before diagnosis is currently possible [22, 13].
However, they also suggest that more robust methods need investigation before
similar deep-learning classifiers achieve clinical strength.
Poor performance in my initial results may be due to differing levels of net-
work optimization. My original individual models for the 12-month data were
built on the same structure as only the best-performing models at 6 months;
further investigation of the appropriate model structures at 12-months may
benefit performance. However, given that the networks exhibit sufficient com-
plexity to learn even the most complex non-linear features, there may be other
avenues worth exploring that prove more beneficial. Examples include (a) learn-
ing appropriate weights and thresholds for the ensemble models (possibly via a
simple neural network of a single layer); (b) investigating additional sampling
approaches; (c) oversampling the minority class (ASD+) beyond what was done
in this study; (d) reducing model complexity; (e) adjusting SMOTE parameters
(e.g., k-neighbors); and (f) exploring additional data options (as explained be-
low). Finally, it is possible that my (unbiased) results demonstrate an optimistic
bias in those of Mostapha; that is, the results reported based on the 6-month
dataset and models may be stronger than the underlying predictive signal due
to some bias in the experimentation. Further review is necessary to determine
whether or not this is the case.
It is known that the brain at 12 months is more heterogeneous than at 6
months. This too may contribute to the poor performance shown in my initial
results, as noisier, more variable data makes identifying a decision boundary a
harder problem. Thus, this and similar studies may be fundamentally limited
by the biology of the brain—individual developmental differences may mask
bio-markers present at earlier stages of development.
In addition to noise from developmental differences, my data contained noise
from processing steps. The EA-CSF in particular was noisier in the Loose
inclusion criteria than in the Strict, offering a simple proxy for comparing model
performance relative to noise in the data. In general, the Loose-based models
performed worse, supporting the conclusion that noisier data is harder to learn
from (all else held constant).
The curse of deep-learning is often a lack of data (especially when the data
is high-dimensional data), and my study is no exception to this. I lacked certain
data parcellations available to the 6-month study (Lobar, Desikan-Killiany) [22].
I lacked an appropriately-sized LR negative control group. It is also possible
that more training data would allow me to retain higher model complexity.
The lack of Lobar parcellations was an important limitation to my study; it
may be that the coarseness of this very-low-dimensional parcellation is enough
to capture important biological features and still maintain low enough model-
complexity to allow accurate and sensitive predictions. I substituted the most
appropriate parcellation I had in order to work around this limitation, but
further studies may look to expand on my results by computing the Lobar
parcellations and evaluating the performance of models that make use of this
new data.
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Lacking an appropriately-sized LR negative control group also limited my
analysis of model performance on a mostly negative group. Whereas Mostapha
was able to evaluate the 6-month ensemble models on a negative control group
and demonstrate comparable performance [22], I could not. The sample size of
the LR group (Strict: 58; Loose: 71) is too low to be statistically meaningful,
and oversampling techniques like SMOTE would be inappropriate for negative
validation. Even Mostapha expressed limitations with the size of the LR group
(n = 102) in [22]. Further work could benefit from additional data collection to
re-evaluate both studies models on a negative control group.
Additional training data is considered a boon for all deep-learning and ma-
chine learning models. In particular, additional data allow more complex models
to learn more complex associations with less risk of over-fitting and a higher like-
lihood of generalization. While I was able to evaluate initial models with the
available data, it is possible that the size of the data (Strict: 164; Loose: 184)
limited the performance. Reducing the model complexity may boost perfor-
mance, as already stated, but additional data collection may also boost perfor-
mance without necessitating reduced model complexity. Additional data can
also be used indirectly to pre-train the model, allowing it to learn in broad
strokes more about the shape of the data it will encounter when actually train-
ing. This kind of “priming” can have substantial benefits, particularly with
non-convex problems.
In the case of the ensemble models, I do see evidence of a signal, in spite of my
failure to achieve or surpass the performance of the 6-month ensemble models.
That is, there is evidence that these types of models can correctly predict ASD
in HR individuals. By swapping out the component models from those most
predictive at 6-months to those most predictive at 12-months, I achieved better
performance than the adapted 6-month ensemble models. It was not enough to
close the gap, but it suggests that further methods or optimization may lead to
clinical-strength classification networks at 12 months of age.
5 Conclusion
In this work, I introduced one problem facing autism spectrum disorder (ASD)
diagnosis and intervention (lack of biomarkers), and I introduced the impacts of
early identification and treatment. Building upon a body of previous research es-
tablishing connections between ASD and (a) increased extra-axial cerebrospinal
fluid (EA-CSF) volume [30, 29]; (b) surface area (SA)-based diagnoses [13]; and
(c) SA-, surface complexity index (SCI)-, EA-CSF-, and cortical thickness (CT)-
based ensemble models at 6 months of age, I developed the necessary process-
ing and analysis to evaluate similar models at 12 months of age. I described
the process by which 12-month magnetic resonance imaging (MRI) images were
used to derive local EA-CSF volumes, which were then used to build deep-
learning models. I also developed a basic introduction to machine learning and
deep learning methods, and discussed an important technique for dimensional-
ity reduction in brain imaging problems. I compared my developed models to
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their 6-month counterparts and found overall trends of worsened performance. I
pushed for better performance by adapting the models to the predictive features
at 12 months, but my efforts ultimately did not achieve performance on par with
the 6-month models. I discussed several reasons for the observed performance,
including (a) network optimization and structure; (b) noise in the data; and
(c) lack of certain brain parcellations. I also considered other limitations that
could be expanded on in the future, such as a lack of training data and negative
control group.
I thus conclude the study on two notes: first, the current progress of research
on predictive ASD biomarkers in early development has yielded fruitful results,
but not yet a clinical-strength classifier. I have contributed to that research by
showing a predictive signal among the 12-month MRI images of high familial
risk (HR) cases, though I failed to discover a classifier of power equal to or
better than current approaches. Second, there remain many possible directions
to explore based on current research and in particular based on this work.
5.1 Further work
In Section 2.1.1, I explained the current mechanism used to extract local EA-
CSF measures from MRI images. The current process is inherently fallible
and caused me to lose a portion of available data. Current research efforts
are investigating other mechanisms to extract this kind of morphometric data,
which may lead to more accurate data or a larger quantity of data. Further
work thus could make use of new data in evaluating predictive models.
In Section 2.2.2, I noted that current deep-learning models make use of adult
brain parcellations to reduce the dimensionality of data. Further work remains
to develop appropriate infant brain parcellations and evaluate their performance
on methods in this work and in [22].
In Section 2.2, I noted several times that my models were left optimized for
performance on 6-month data. Further studies could explore further optimiza-
tions of and tweaks to these models, such as (a) learning appropriate weights
and thresholds for the ensemble models (possibly via a simple neural network
of a single layer); (b) investigating additional sampling approaches; (c) explor-
ing ways to reduce model complexity; (d) making use of computed Lobar and
Desikan-Killiany parcellations; or (e) making use of additional data sets (either
for training, pre-training, or validation), as explored in Section 4.
Ultimately, further research is needed to determine whether a combination
of brain morphometric measurements or additional classifier optimization may
lead to a sufficiently accurate prediction for clinical predictive use.
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ADDM Autism and Developmental Disabilities Moni-
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APA American Psychiatric Association
ASD autism spectrum disorder
CDC Centers for Disease Control
CT cortical thickness
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HR high familial risk
IBIS Infant Brain Imaging Study
ICV intra-cranial cavity volume
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MLP multi-layer perceptron
MRI magnetic resonance imaging
NPV negative predictive value
PPV positive predictive value
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